Clinical Trials Browser

INDUSTRY × Gastrointestinal Neoplasms × camrelizumab × Clear all

NCT02742935 2023-02-27

A Study to Evaluate the Safety and Tolerability of Using SHR-1210 by Advanced Solid Tumor Subjects

Phase 1 Completed

BreastGastrointestinal

Breast Neoplasms, Gastrointestinal Neoplasms